Three Treatments for EGFR-Mutant Non-Small-Cell Lung Cancer with Brain Metastases

被引：0
|
作者：
Fan, Y. [1 ]
Yu, X. [2 ]
Wang, H. [2 ]
机构：
[1] Zhejiang Canc Hosp, Chemotherapy, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Canc Hosp, Thorac Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Epidermal growth factor receptor; Tyrosine kinase inhibitors; brain metastases;
D O I：
10.1016/j.jtho.2017.09.1510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-069
引用
收藏
页码：S2228 / S2228
页数：1
相关论文
共 50 条
  • [21] Real-World Data on Prognostic Factors for Overall Survival in EGFR-Mutant Non-Small-Cell Lung Cancer Patients with Brain Metastases
    Yu, Xiaoqing
    Fan, Yun
    JOURNAL OF CANCER, 2019, 10 (15): : 3486 - 3493
  • [22] Afatinib-refractory brain metastases from EGFR-mutant non-small-cell lung cancer successfully controlled with erlotinib: a case report
    Nonagase, Yoshikane
    Okamoto, Kunio
    Iwasa, Tsutomu
    Yoshida, Takeshi
    Tanaka, Kaoru
    Takeda, Masayuki
    Kaneda, Hiroyasu
    Shimizu, Toshio
    Tsurutani, Junji
    Nakagawa, Kazuhiko
    ANTI-CANCER DRUGS, 2016, 27 (03) : 251 - 253
  • [23] AZD9291 in EGFR-mutant advanced non-small-cell lung cancer patients
    Remon, Jordi
    Planchard, David
    FUTURE ONCOLOGY, 2015, 11 (22) : 3069 - 3081
  • [24] The safety and efficacy of erlotinib and ramucirumab combination in EGFR-mutant non-small-cell lung cancer
    Boussageon, Maxime
    Swalduz, Aurelie
    Perol, Maurice
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (10) : 1071 - 1080
  • [25] Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer
    Caressa Hui
    Vera Qu
    Jen-Yeu Wang
    Rie von Eyben
    Yu-Cheng Chang
    Po-Lin Chiang
    Chih-Hung Liang
    Jen-Tang Lu
    Gordon Li
    Melanie Hayden-Gephart
    Heather Wakelee
    Joel Neal
    Kavitha Ramchandran
    Millie Das
    Seema Nagpal
    Scott Soltys
    Nathaniel Myall
    Erqi Pollom
    Journal of Neuro-Oncology, 2022, 160 : 233 - 240
  • [26] Local Control of Brain Metastases with Osimertinib Alone in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
    Hui, C.
    Qu, V.
    Wang, J. Y.
    Von Eyben, R.
    Chang, Y. C.
    Chiang, P. L.
    Liang, C. H.
    Lin, J. Y.
    Lu, J. T.
    Li, G.
    Hayden, M.
    Myall, N.
    Soltys, S. G.
    Pollom, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E54 - E55
  • [27] Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer
    Hui, Caressa
    Qu, Vera
    Wang, Jen-Yeu
    von Eyben, Rie
    Chang, Yu-Cheng
    Chiang, Po-Lin
    Liang, Chih-Hung
    Lu, Jen-Tang
    Li, Gordon
    Hayden-Gephart, Melanie
    Wakelee, Heather
    Neal, Joel
    Ramchandran, Kavitha
    Das, Millie
    Nagpal, Seema
    Soltys, Scott
    Myall, Nathaniel
    Pollom, Erqi
    JOURNAL OF NEURO-ONCOLOGY, 2022, 160 (01) : 233 - 240
  • [28] Is It Time to Implement Adjuvant Targeted Therapy in EGFR-Mutant Non-Small-Cell Lung Cancer?
    Kulkarni, Amit A.
    Naqash, Abdul Rafeh
    Puri, Sonam
    Dienstmann, Rodrigo
    JCO PRECISION ONCOLOGY, 2021, 5 : 408 - 414
  • [29] Erlotinib response EGFR-mutant gefitinib-resistant non-small-cell lung cancer
    Chang, John Wen-Cheng
    Chou, Chun-Liang
    Huang, Shiu-Feng
    Wang, Hung-Ming
    Hsieh, Jia-Juan
    Hsu, Todd
    Cheung, Yun-Chung
    LUNG CANCER, 2007, 58 (03) : 414 - 417
  • [30] Distinct concomitant genetic alterations in EGFR-mutant non-small cell lung cancer patients with brain metastases
    Fan, Y.
    Yu, S.
    Xu, Y.
    Huang, Z.
    Li, H.
    Chen, K.
    Gong, L.
    Xu, X.
    ANNALS OF ONCOLOGY, 2022, 33 : S62 - S62
12345